| アブストラクト | Since the issuance of the emergency use authorization (EUA) of 3 coronavirus disease 2019 (COVID-19) vaccines, there have been over 180 million individuals fully vaccinated in the United States (US). With the increasing administration of COVID-19 vaccinations, there have been over 550,000 adverse events reported in the Vaccine Adverse Event Reporting System (VAERS) with approximately 230,000 experienced after receipt of the Pfizer-BioNTech COVID-19 Vaccine as of September 23(rd) 2021. Audio-vestibular symptoms (including Sudden Sensorineural Hearing Loss (SSNHL)) secondary to immunizations has previously been evaluated. However, this report describes the first case of bilateral sudden sensorineural hearing loss potentially due to the Pfizer-BioNTech COVID-19 vaccine. We further review the available literature regarding the treatment of Sudden Sensorineural Hearing Loss, and the association of SSNHL with previous immunizations and COVID-19 infection. Lastly, we hypothesize the underlying potential mechanisms between SSNHL and the Pfizer-BioNTech COVID-19 vaccine. |
|---|
| ジャーナル名 | Journal of pharmacy practice |
|---|
| Pubmed追加日 | 2022/12/21 |
|---|
| 投稿者 | Andrade, Justin; Sessa, Lauren; Ephrat, Moshe; Truong, James; DiGregorio, Robert |
|---|
| 組織名 | Department of Pharmacy Practice, Touro College of Pharmacy, New York, NY, USA.;RINGGOLD: 471068;Pharmacotherapy Department, The Brooklyn Hospital Center, Brooklyn, NY, USA.;RINGGOLD: 24508;ENT & Allergy Associates LLP, Lake Success, NY, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36537083/ |
|---|
